ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/06/21 | 1,400 | 1,443 | 1,359 | 1,400 | +24 | +1.7% | 879,100 |
2018/06/20 | 1,314 | 1,385 | 1,304 | 1,376 | +48 | +3.6% | 925,500 |
2018/06/19 | 1,442 | 1,445 | 1,325 | 1,328 | -124 | -8.5% | 1,494,000 |
2018/06/18 | 1,484 | 1,521 | 1,428 | 1,452 | -133 | -8.4% | 1,327,400 |
2018/06/15 | 1,605 | 1,645 | 1,567 | 1,585 | -47 | -2.9% | 1,067,200 |
2018/06/14 | 1,588 | 1,682 | 1,561 | 1,632 | +20 | +1.2% | 3,163,200 |
2018/06/13 | 1,520 | 1,653 | 1,519 | 1,612 | +165 | +11.4% | 6,141,800 |
2018/06/12 | 1,426 | 1,466 | 1,400 | 1,447 | +10 | +0.7% | 1,138,600 |
2018/06/11 | 1,481 | 1,492 | 1,391 | 1,437 | -55 | -3.7% | 2,384,500 |
2018/06/08 | 1,275 | 1,560 | 1,266 | 1,492 | +232 | +18.4% | 8,196,600 |
2018/06/07 | 1,215 | 1,283 | 1,203 | 1,260 | +72 | +6.1% | 1,056,900 |
2018/06/06 | 1,222 | 1,234 | 1,172 | 1,188 | -28 | -2.3% | 934,600 |
2018/06/05 | 1,235 | 1,272 | 1,210 | 1,216 | -24 | -1.9% | 872,200 |
2018/06/04 | 1,330 | 1,330 | 1,223 | 1,240 | -80 | -6.1% | 1,297,900 |
2018/06/01 | 1,343 | 1,373 | 1,308 | 1,320 | -40 | -2.9% | 719,500 |
2018/05/31 | 1,310 | 1,403 | 1,308 | 1,360 | +54 | +4.1% | 1,409,600 |
2018/05/30 | 1,342 | 1,357 | 1,302 | 1,306 | -77 | -5.6% | 795,400 |
2018/05/29 | 1,388 | 1,389 | 1,313 | 1,383 | +41 | +3.1% | 967,600 |
2018/05/28 | 1,350 | 1,384 | 1,326 | 1,342 | -2 | -0.1% | 680,800 |
2018/05/25 | 1,340 | 1,400 | 1,328 | 1,344 | -8 | -0.6% | 924,100 |
2018/05/24 | 1,424 | 1,436 | 1,348 | 1,352 | -65 | -4.6% | 1,237,000 |
2018/05/23 | 1,443 | 1,481 | 1,414 | 1,417 | -43 | -2.9% | 808,300 |
2018/05/22 | 1,455 | 1,540 | 1,426 | 1,460 | +10 | +0.7% | 1,386,100 |
2018/05/21 | 1,431 | 1,485 | 1,430 | 1,450 | +2 | +0.1% | 534,100 |
2018/05/18 | 1,430 | 1,456 | 1,401 | 1,448 | -12 | -0.8% | 851,600 |
2018/05/17 | 1,430 | 1,477 | 1,418 | 1,460 | +15 | +1% | 525,600 |
2018/05/16 | 1,514 | 1,521 | 1,437 | 1,445 | -85 | -5.6% | 1,034,300 |
2018/05/15 | 1,629 | 1,639 | 1,519 | 1,530 | -69 | -4.3% | 940,300 |
2018/05/14 | 1,550 | 1,685 | 1,535 | 1,599 | +65 | +4.2% | 1,264,700 |
2018/05/11 | 1,547 | 1,564 | 1,506 | 1,534 | -42 | -2.7% | 682,200 |
2018/05/10 | 1,555 | 1,594 | 1,554 | 1,576 | +19 | +1.2% | 397,500 |
2018/05/09 | 1,566 | 1,576 | 1,533 | 1,557 | -33 | -2.1% | 472,200 |
2018/05/08 | 1,536 | 1,614 | 1,520 | 1,590 | +48 | +3.1% | 724,000 |
2018/05/07 | 1,571 | 1,589 | 1,536 | 1,542 | -55 | -3.4% | 465,400 |
2018/05/02 | 1,557 | 1,608 | 1,555 | 1,597 | +29 | +1.8% | 328,200 |
2018/05/01 | 1,584 | 1,598 | 1,547 | 1,568 | -31 | -1.9% | 585,800 |
2018/04/27 | 1,623 | 1,627 | 1,589 | 1,599 | -11 | -0.7% | 444,400 |
2018/04/26 | 1,673 | 1,679 | 1,600 | 1,610 | -63 | -3.8% | 821,100 |
2018/04/25 | 1,623 | 1,697 | 1,619 | 1,673 | +44 | +2.7% | 550,200 |
2018/04/24 | 1,664 | 1,730 | 1,623 | 1,629 | -21 | -1.3% | 1,082,200 |
2018/04/23 | 1,617 | 1,657 | 1,585 | 1,650 | +33 | +2% | 573,500 |
2018/04/20 | 1,600 | 1,647 | 1,583 | 1,617 | +17 | +1.1% | 527,900 |
2018/04/19 | 1,630 | 1,637 | 1,575 | 1,600 | -21 | -1.3% | 710,000 |
2018/04/18 | 1,670 | 1,677 | 1,611 | 1,621 | -50 | -3% | 816,500 |
2018/04/17 | 1,642 | 1,709 | 1,605 | 1,671 | +51 | +3.1% | 1,201,300 |
2018/04/16 | 1,650 | 1,693 | 1,596 | 1,620 | -41 | -2.5% | 642,600 |
2018/04/13 | 1,640 | 1,682 | 1,620 | 1,661 | +26 | +1.6% | 639,200 |
2018/04/12 | 1,711 | 1,716 | 1,618 | 1,635 | -75 | -4.4% | 1,134,000 |
2018/04/11 | 1,781 | 1,831 | 1,701 | 1,710 | -84 | -4.7% | 1,619,200 |
2018/04/10 | 1,764 | 1,813 | 1,739 | 1,794 | +14 | +0.8% | 613,200 |
1751~
1800
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
Chordia | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム